Pancreatic Cancer Research

ResearcherYokohama City University HospitalNo recent work listed

Takashi Kaneko

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9368-1658; OpenAlex author ID A5101453497. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 3

  1. Randomized Phase II Study of Gemcitabine Monotherapy vs. Gemcitabine with an EPA-Enriched Oral Supplement in Advanced Pancreatic Cancer. Co-author DOI 10.1080/01635581.2020.1871495↗
  2. Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy. Co-author DOI 10.1111/cas.14245↗
  3. Combination chemotherapy with gemcitabine and nab-paclitaxel for a metastatic pancreatic ductal adenocarcinoma patient undergoing hemodialysis. Co-author DOI 10.1007/s12328-019-00976-w↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuichiro Tozuka · 2 shared papers, 2019–2020 · strength 0.18
  2. Shin Maeda · 2 shared papers, 2019–2020 · strength 0.18
  3. Shinichi Ohkawa · 1 shared paper, 2022 · strength 0.16
  4. Takeharu Yamanaka · 1 shared paper, 2022 · strength 0.16
  5. Satoshi Kobayashi · 1 shared paper, 2022 · strength 0.16
  6. Manabu Morimoto · 1 shared paper, 2022 · strength 0.16
  7. Makoto Ueno · 1 shared paper, 2022 · strength 0.16
  8. Makoto Sugimori · 1 shared paper, 2020 · strength 0.08
  9. Masatsugu Nagahama · 1 shared paper, 2020 · strength 0.08
  10. Yoshimasa Suzuki · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.